Middle East and Africa Oncology Research
20 comprehensive market analysis studies and research reports on the Middle East and Africa Oncology sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 226 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
North America Uterine Cancer Therapeutics and Diagnostics Market
CAGR: 4.18%
Study Period: 2020 - 2031
South America Pancreatic Cancer Therapeutics and Diagnostics Market
CAGR: 6.5%
Study Period: 2020 - 2031
United States Melanoma Diagnostics and Therapeutics Market
CAGR: 8.66%
Study Period: 2020 - 2031
South America Bladder Cancer Therapeutics and Diagnostics Market
CAGR: 3%
Study Period: 2019 - 2030
Europe Bladder Cancer Therapeutics and Diagnostics Market
CAGR: 5%
Study Period: 2019 - 2030
Healthcare
Categories
20 Healthcare Reports
Categories
Filters and Sort
Showing 20 of 20 results in Oncology
Gallbladder Cancer Market
CAGR: 5.75%
Study Period: 2020 - 2031
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Merck, AstraZeneca, Bristol-Myers Squibb, Roche, Pfizer
Starting at:$4,750
Fallopian Tube Cancer Market
CAGR: 7.76%
Study Period: 2020 - 2031
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:AstraZeneca, GlaxoSmithKline, Roche, Merck, Abbvie
Starting at:$4,750
Prostate Cancer Market
CAGR: 8.29%
Study Period: 2020 - 2031
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Bayer, AstraZeneca, Sanofi, Thermo Fisher Scientific, Roche
Starting at:$4,750
Bladder Cancer Therapeutics And Diagnostics Market
CAGR: 6.12%
Study Period: 2020 - 2031
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Bristol-Myers Squibb Company, GlaxoSmithKline, Merck, Johnson & Johnson, Roche
Starting at:$4,750
Colorectal Cancer Diagnostics And Therapeutics Market
CAGR: 4.89%
Study Period: 2020 - 2031
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Epigenomics, Abbott Laboratories, Roche, Novigenix, Amgen
Starting at:$4,750
Radiotherapy Market
CAGR: 7.08%
Study Period: 2020 - 2031
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:GE Healthcare, Accuray, Siemens Healthineers, IsoRay, Elekta
Starting at:$4,750
Prostate Health Market
CAGR: 9.18%
Study Period: 2020 - 2031
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Teleflex, Novartis, Elekta, Siemens Healthineers, Bayer
Starting at:$4,750
Precision Oncology Market
CAGR: 9.53%
Study Period: 2020 - 2031
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Roche, Illumina, Labcorp (Invitae Corporation), Novartis, Thermo Fisher Scientific
Starting at:$4,750
Soft Tissue Sarcoma Market
CAGR: 8.75%
Study Period: 2020 - 2031
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Roche, Novartis, Bayer, Pfizer, Merck
Starting at:$4,750
Pituitary Cancer Market
CAGR: 9.21%
Study Period: 2020 - 2031
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Novartis, Pfizer, Ipsen, Recordati S.p.A., Camurus AB
Starting at:$4,750
Pancreatic Cancer Therapeutics And Diagnostics Market
CAGR: 7.08%
Study Period: 2020 - 2031
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Myriad Genetics, Pfizer, Novartis, AstraZeneca, Immunovia
Starting at:$4,750
Kidney Cancer Therapeutics and Diagnostics Market
CAGR: 4.86%
Study Period: 2021 - 2030
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Amgen, Bayer, Roche, Bristol-Myers Squibb, Abbott Laboratories
Starting at:$4,750
Cervical Cancer Diagnostics And Therapeutics Market
CAGR: 5.37%
Study Period: 2020 - 2031
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Novartis, Beckton Dickinson, Abbott Laboratories, Roche, GlaxoSmithKline
Starting at:$4,750
Global Melanoma Diagnostics and Therapeutics Market
CAGR: 15.1%
Study Period: 2019 - 2030
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Abbott Laboratories, Amgen, Bristol-Myers Squibb, Novartis, Roche
Starting at:$4,750
MEA Bladder Cancer Therapeutics & Diagnostics Market
CAGR: 5.6%
Study Period: 2019 - 2030
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Pfizer, Johnson & Johnson, AstraZeneca, Bristol-Myers Squibb, Merck
Starting at:$4,750
Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market
CAGR: 5.2%
Study Period: 2021 - 2030
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Bayer, Roche, Bristol-Myers Squibb, Abbott Laboratories, Amgen
Starting at:$4,750
Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Market
CAGR: 7.90%
Study Period: 2019 - 2030
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:AstraZeneca, Bristol-Myers Squibb, Roche, Johnson & Johnson, Siemens Healthineers
Starting at:$4,750
Ovarian Cancer Diagnostics and Therapeutics Market
CAGR: 9.5%
Study Period: 2021 - 2030
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Roche, Siemens Healthineers
Starting at:$4,750
Uterine Cancer Therapeutics And Diagnostics Market
CAGR: 6.26%
Study Period: 2020 - 2031
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Abbott Laboratories, Beckton Dickinson, Merck, Roche, GlaxoSmithKline
Starting at:$4,750
MEA Uterine Cancer Therapeutics & Diagnostics Market
CAGR: 5.7%
Study Period: 2019 - 2030
Starting at:$4,750
Region Covered: Middle East and Africa
Major Players:Abbott Laboratories, Merck, Takeda Pharmaceuticals, Siemens Healthineers, Roche
Starting at:$4,750
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.